Unlocking the Potential of TVP23C-CDRT4: A Promising Drug Target and Biomarker

Target Name: TVP23C-CDRT4

NCBI ID: G100533496

TVP23C-CDRT4

Unlocking the Potential of TVP23C-CDRT4: A Promising Drug Target and Biomarker

TVP23C-CDRT4, also known as CD28, is a protein that is expressed in various tissues of the human body, including the brain, pancreas, and gastrointestinal tract. Its unique structure and expression pattern have piqued the interest of researchers due to its potential involvement in various diseases. This article will explore the potential of TVP23C-CDRT4 as a drug target and biomarker.

Potential Drug Target

TVP23C-CDRT4 has been identified as a potential drug target due to its unique structure and its involvement in various cellular processes. One of its key features is its ability to interact with various signaling pathways, including the T cell receptor signaling pathway. This interaction allows TVP23C-CDRT4 to play a crucial role in regulating immune responses and has implications for the development of autoimmune diseases.

In addition to its role in immune regulation, TVP23C-CDRT4 has also been shown to be involved in various signaling pathways related to cell survival, angiogenesis, and plasticity. These involvement in these processes make it an attractive target for drug development.

Potential Biomarker

TVP23C-CDRT4 has also been identified as a potential biomarker for various diseases, including cancer. Its expression has been observed in various types of cancer, including brain, breast, and ovarian cancer. This suggests that TVP23C-CDRT4 may be a useful biomarker for the diagnosis and evaluation of these diseases.

One of the key advantages of using TVP23C-CDRT4 as a biomarker is its stability and its ability to be easily detected in various types of cancer tissues. This makes it a promising tool for the development of new diagnostic tests and for the evaluation of cancer-related therapies.

Other Potential Applications

In addition to its potential as a drug target and biomarker, TVP23C-CDRT4 has other potential applications in various fields, including regenerative medicine and tissue engineering. Its unique structure and its ability to interact with signaling pathways make it an attractive tool for the development of new tissue engineering strategies and for the regulation of cellular processes that are important for tissue regeneration.

Conclusion

In conclusion, TVP23C-CDRT4 is a protein that has the potential to be a drug target and a biomarker for various diseases. Its unique structure and its involvement in various cellular processes make it an attractive target for drug development and for the development of new diagnostic tests. As research continues to advance, the potential of TVP23C-CDRT4 as a drug target and biomarker will continue to grow.

Protein Name: TVP23C-CDRT4 Readthrough

The "TVP23C-CDRT4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TVP23C-CDRT4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets